The FDA has granted accelerated approval to zenocutuzumab for treating patients with advanced pancreatic cancer or non-small cell lung cancer with an alteration called an NRG1 gene fusion, based on a ...
The FDA approved a new cancer treatment called Bizengri for adults with certain types of lung and pancreatic cancers. The approval is the first for a treatment designed for cancers with an NRG1 gene ...